Scinai Immunotherapeutics Ltd. (SCNI)
USD 2.0
(2.04%)
USD 2.0
(2.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 512.67 Thousand | - | - | - | - | - |
| Gross Profit | -512.67 Thousand | - | - | - | - | - |
| Operating Expenses | 9.17 Million | 11.06 Million | 11.19 Million | -7.32 Million | 285.5 Million | 71.3 Million |
| Selling, General and Administrative Expenses | 3.98 Million | 5.29 Million | 7.7 Million | 16.67 Million | 34.08 Million | 4.76 Million |
| Research and Development Expenses | 5.19 Million | 5.76 Million | 3.32 Million | 51.41 Million | 250.13 Million | 66.53 Million |
| Other Expenses | - | - | - | 6.83 Million | - | - |
| Cost and Expenses | 9.68 Million | 11.06 Million | 11.19 Million | -7.32 Million | 285.5 Million | 71.3 Million |
| Operating Income | -9.71 Million | -11.06 Million | -11.19 Million | 7.32 Million | -285.5 Million | -71.3 Million |
| Interest Expense | - | - | 3.48 Million | 15.61 Million | 54.36 Million | 12.57 Million |
| Income Tax Expense | 0.28 | 333.51 Thousand | 3.48 Million | -26.34 Million | 54.36 Million | 21.55 Million |
| Earnings before Tax | -6.48 Million | -5.79 Million | -12.84 Million | -4.45 Million | -397.89 Million | -81.16 Million |
| Net Income | -6.5 Million | -5.79 Million | -12.84 Million | -4.45 Million | -397.89 Million | -81.16 Million |
| Earnings Per Share Basic | -16.62 | -40.25 | -125.96 | -40.48 | -4912.27 | -1248.71 |
| Earnings Per Share Diluted | -16.60 | -30.74 | -91.02 | -40.16 | -4872.41 | -1241.91 |
| Weighted Average Shares Outstanding | 390 Thousand | 144 Thousand | 102 Thousand | 110 Thousand | 81 Thousand | 65 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 390.65 Thousand | 188.51 Thousand | 141.14 Thousand | 110.81 Thousand | 81.66 Thousand | 65.35 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -5.96 Million | -36.91 Million | -32.44 Million | 11.16 Million | -76.7 Million | -76.8 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 282.96 Thousand | - | - | - | - | - |
| Cost of Revenue | 940.55 Thousand | 157.73 Thousand | - | 84.91 Thousand | 144.53 Thousand | 145.33 Thousand |
| Gross Profit | -657.59 Thousand | -157.73 Thousand | - | -84.91 Thousand | -144.53 Thousand | -145.33 Thousand |
| Operating Expenses | 1.23 Million | 1.92 Million | 6.63 Million | 1.82 Million | 2.1 Million | 2.59 Million |
| Selling, General and Administrative Expenses | 22.91 Thousand | 484 Thousand | - | 1.2 Million | 968 Thousand | 1.14 Million |
| Research and Development Expenses | 1.21 Million | 1.56 Million | - | 627 Thousand | 1.13 Million | 1.45 Million |
| Other Expenses | 124 Thousand | - | - | - | - | - |
| Cost and Expenses | 2.17 Million | 1.92 Million | 6.63 Million | 1.82 Million | 2.1 Million | 2.59 Million |
| Operating Income | -1.89 Million | -1.92 Million | -9.71 Million | -1.82 Million | -2.1 Million | -2.74 Million |
| Interest Expense | 295 Thousand | 231 Thousand | - | - | - | - |
| Income Tax Expense | -1.00 | 112.72 Thousand | 0.28 | 40.18 Thousand | 184.58 Thousand | 24.91 Thousand |
| Earnings before Tax | -2.31 Million | -2.15 Million | -6.5 Million | -2.33 Million | 3.1 Million | -3.76 Million |
| Net Income | -2.31 Million | -2.15 Million | -6.5 Million | -2.33 Million | 3.1 Million | -3.76 Million |
| Earnings Per Share Basic | -2.76 | -4.27 | - | -9.63 | 25.26 | -12.02 |
| Earnings Per Share Diluted | -2.76 | -4.26 | - | -7.76 | 25.26 | -11.13 |
| Weighted Average Shares Outstanding | 837.35 Thousand | 506 Thousand | 390 Thousand | 242 Thousand | 469 Thousand | 313 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 837.35 Thousand | 506.53 Thousand | 390.65 Thousand | 300.38 Thousand | 469.22 Thousand | 337.96 Thousand |
| Gross Margin | -2.32 | - | - | - | - | - |
| EBIT Margin | -4.95 | - | - | - | - | - |
| Profit Margin | -8.18 | - | - | - | - | - |
| EBITDA | -1.4 Million | -1.77 Million | - | -1.73 Million | -1.95 Million | -2.59 Million |
| Earnings Before Tax Margin | -6.70 | - | - | - | - | - |
MNPR3
IMB
AST
SGIOF
JNEO
071050